Ishami Mpuzamahanga

Ku ya 17 Nyakanga, Ikigo gishinzwe Isuzuma ry'Imiti (CDE) cy'Ikigo cy'Igihugu gishinzwe Ibikoresho by'Ubuvuzi (NMPA) cyatangaje ko ubusabe bwo kwamamaza bwa Trastuzumab Deruxtecan (Enhertu®) bwo kuvura kanseri y'igifu bwemewe ku mugaragaro na NMPA. Ubu busabe burashyirwa...Soma byinshi»

Vuba aha, Ascentage Pharma yatangaje ko umuti wayo mushya wihariye wa Bcl-2 selective inhibitor lisaftoclax (APG-2575) wemejwe n'Ikigo cy'Igihugu cy'Ubuvuzi mu Bushinwa (NMPA) mu kuvura abarwayi bakuru bafite kanseri y'amaraso idakira/lymphoma ntoya (CLL/SLL)...Soma byinshi»

GenFleet Therapeutics iherutse gutangaza ko Ikigo gishinzwe imiti (ISAF) mu Karere k’Ubushinwa gashinzwe imiyoborere yihariye ya Macau cyemeje Dupert® (fulzerasib, GFH925/IBI351) ku kuvura abarwayi barwaye kanseri y’ibihaha itari iy’uturemangingo duto (NSCLC) ifite KRAS G12C mutati...Soma byinshi»

Ku ya 30 Kamena, umuti wa Avistone wo mu bwoko bwa Vebreltinib wakozwe ku giti cye wahawe uburenganzira bwo kuvura abarwayi bafite kanseri y’ibihaha idakomeye cyangwa isanzwe (NSCLC) ifite MET amplifice...Soma byinshi»

Ku ya 30 Kamena 2025, HUTCHMED yatangaje ko Porogaramu nshya y'imiti (NDA) yo guhuza ORPATHYS (savolitinib) na TAGRISSO (osimertinib) yemejwe n'Ikigo cy'Igihugu cy'Ubushinwa gishinzwe Ibikoresho by'Ubuvuzi (NMPA) mu kuvura abarwayi bafite indwara ziterwa n'imiti isanzwe cyangwa iterwa n'imiti isanzwe...Soma byinshi»

Ku ya 30 Kamena, urubuga rwemewe rw’Ikigo cy’Igihugu gishinzwe Ibikoresho by’Ubuvuzi (NMPA) rwatangaje ko Anlotinib, umuti mushya wo mu cyiciro cya mbere wakozwe na Chia Tai Tianqing, wemerewe ikimenyetso gishya mu Bushinwa: uburyo bwo kuvura buvanze na chimiotherapie ku barwayi ba mbere ...Soma byinshi»

Ku ya 26 Kamena 2025, CARsgen yatangaje ko Ikigo cy'Igihugu gishinzwe Ibikoresho by'Ubuvuzi (NMPA) cyo mu Bushinwa cyemeye Ubusabe Bushya bw'Imiti (NDA) kuri satricabtagene autoleucel ("satri-cel", CT041) (umuti wa CAR T-cell ukomoka kuri poroteyine Claudin18.2) mu kuvura Claudi...Soma byinshi»

Ku ya 19 Kamena, Ikigo gishinzwe Isuzuma ry'Imiti (CDE) cy'Ikigo cy'Igihugu gishinzwe Ibikoresho by'Ubuvuzi (NMPA) cyatangaje ko inshinge za LM-108 za Livzon Pharmaceutical zatanzwe kugira ngo zishyirwe mu cyiciro cy'ubuvuzi bugezweho. Guhuza inshinge za Kefeqibai monoclonal antibody (LM-1...Soma byinshi»

Ku ya 19 Kamena, Ikigo Gishinzwe Isuzuma ry'Imiti (CDE) cy'Ikigo cy'Igihugu Gishinzwe Ibikoresho by'Ubuvuzi (NMPA) cyatangaje ko IBI343 ya Innovent Biologics yatanzwe kugira ngo ishyirwe muri gahunda yo kuvura indwara zidasanzwe, igamije kuvura indwara ziteye imbere cyangwa ziterwa n'imiti...Soma byinshi»

Ku ya 6 Kamena, ikinyamakuru mpuzamahanga cy’ubuvuzi cyitwa Journal of Hematology & Oncology cyasohoye ibyavuye mu bushakashatsi bwa phase I/II (KL264-01/MK-2870-001) bwa TROP2 ADC sacituzumab tirumotecan (sac-TMT) nk'uburyo bwo kuvura kanseri idakira cyangwa ikwirakwira mu gace runaka idakira, idakira...Soma byinshi»

Ku ya 10 Kamena, Ikigo gishinzwe Isuzuma ry'Imiti (CDE) cy'Ikigo cy'Igihugu gishinzwe Ibikoresho by'Ubuvuzi (NMPA) cyatangaje ko umuti wa Trastuzumab Deruxtecan (T-DXd, DS-8201a) uteganijwe guhabwa isuzuma ry'ibanze mu kuvura abarwayi bakuru bafite ikibazo cy'igifu cya HER2 cyateye imbere mu gace runaka cyangwa cyaranduye...Soma byinshi»

Mu minsi ishize, Merck & Co., Inc. (Merck) yatangaje ko umuti wayo wo gukumira PD-1, pembrolizumab, wemejwe n'Ikigo cy'Igihugu gishinzwe Ibikoresho by'Ubuvuzi (NMPA) cyo mu Bushinwa kugira ngo ukoreshwe hamwe na lenvatinib na transarterial chemoembolization (TACE) mu kuvura abarwayi badafite udukoko ...Soma byinshi»